Wolverine Trading’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Wolverine Trading’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,764	Closed	-$67K	–	5254
2023 Q1	$67K	Buy	+15,764	New	+$81.8K	﹤0.01%	3772
2022 Q4	–	Sell	-22,639	Closed	-$127K	–	5483
2022 Q3	$127K	Buy	+22,639	New	+$141K	﹤0.01%	3820
2022 Q2	–	Sell	-47,182	Closed	-$236K	–	6261
2022 Q1	$236K	Buy	47,182 +29,063	+160%	+$86.7K	﹤0.01%	4203
2021 Q4	$45K	Sell	18,119 -5,134	-22%	-$12.6K	﹤0.01%	5352
2021 Q3	$68K	Buy	+23,253	New	+$63.3K	﹤0.01%	5943
2018 Q4	–	Sell	-14,622	Closed	-$24K	–	5905
2018 Q3	$32K	Buy	14,622 +3,818	+35%	+$9.45K	﹤0.01%	4769
2018 Q2	$42K	Hold	10,804	–	–	﹤0.01%	4939
2018 Q1	$42K	Buy	+10,804	New	+$38K	﹤0.01%	4939

Other funds holding CTIC

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Wolverine Trading's CTIC Position: Q2 2023 in Review

Wolverine Trading sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 15,764 shares — an estimated $67K sold.

Wolverine Trading first reported a position in CTIC in Q1 2018 and held it in 8 quarters. The position peaked at $236K in Q1 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

Wolverine Trading reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
Wolverine Trading sold 15,764 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $67K.
Wolverine Trading first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2018 and held it in 8 quarters.
Wolverine Trading's CTI BioPharma Corp. (DE) Common Stock position peaked at $236K in Q1 2022.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Wolverine Trading's 13F filing for Q2 2023, filed 23 Aug 2023.